ABSTRACT
A novel 4-aminoquinoline derivative [(
S
)-7-chloro-
N
-(4-methyl-1-(4-methylpiperazin-1-yl)pentan-2-yl)-quinolin-4-amine triphosphate] exhibiting curative activity against chloroquine-resistant malaria parasites has been identified for preclinical development as a blood schizonticidal agent. The lead molecule selected after detailed structure-activity relationship (SAR) studies has good solid-state properties and promising activity against
in vitro
and
in vivo
experimental malaria models. The
in vitro
absorption, distribution, metabolism, and excretion (ADME) parameters indicate a favorable drug-like profile.
摘要
一种新型
4-氨基喹啉衍
生物 [(
S
)-7-
氯-
N
-(4-甲基-1-(4-甲基
哌嗪-1-基)
戊烷-2-基)-
喹啉-4-胺
三磷酸酯]对耐
氯喹的疟原虫具有治疗活性,已被确定作为血吸虫杀灭剂进行临床前开发。经过详细的结构-活性关系(
SAR)研究后选出的先导分子具有良好的固态特性,对
体外
和
体内
实验疟疾模型具有良好的活性。体外
体外
吸收、分布、代谢和排泄(A
DME)参数表明其具有良好的类药物特征。